Free Trial

Try CR Comply Free: AML, Sanctions and PEP Screening for MEA.

CR Comply checks any company or individual against global sanctions, watchlists, PEP lists and adverse media in seconds, with specialist coverage for MEA markets where public records are fragmented.
Use the free trial to screen your own clients, partners and suppliers and see whether the results fit your screening policy before you commit to a plan.

Request a Free Trial

What You Can Explore in Your Trial

50.5+

Instant sanctions, watchlist, PEP and adverse media checks on any entity or individual

4.1+

Beneficial ownership and corporate linkage, so you see the people behind the company

32.6+

Ongoing monitoring with instant alerts when a risk profile changes

10.6+

A timestamped, audit-ready evidence trail for every screen

32.6+

Configurable risk thresholds, so screening follows your own compliance policy

32.6+

Access through web platform, API or batch files

Don’t Let Unreliable Data Derail Your Growth!

Incomplete unreliable data and limited risk visibility don't just slow your company down; they actively sabotage its growth. Without comprehensive standardised, reliable quality data, you expose your business to unnecessary risks which complicate your ability to analyse the market landscape, and develop effective strategies.

Worse yet, compliance missteps, especially in new markets, can lead to costly fines that stifle your growth and tarnish your reputation. All this is also compounded by slow, manual processes that leave you scrambling to keep up, ultimately costing you deals, partnerships, and valuable time.

The thing is, high growth often means high-risk exposure, and the only way to navigate risk is through data. When harnessed correctly, data serves as your north star, guiding you through the maze of growth.

Why Trust Us

25+ years of MEA data expertise

Founded in 1997, Cedar Rose has built business data across the Middle East and Africa for over 25 years, serving over 200 organisations worldwide. Local knowledge reaches the entities and owners global tools often miss.

Powered by ComplyAdvantage

CR Comply runs on a category-leading, AI-driven financial crime risk platform. Cedar Rose adds specialist MEA coverage, so results reflect both global and regional risk.

Part of Coface

Cedar Rose is part of Coface, a global group in credit insurance and risk. You get the stability of an international group with the focus of a regional specialist.

The Coverage Behind Your Trial

Fresh data every day, the global lists you need and the regional depth to screen with confidence across the Middle East and Africa.

30,000

Daily profile updates. Your screening reflects today's status, not last quarter's.

250+

Countries covered, including markets where public records are fragmented.

Languages monitored for adverse media.

10,000

New profiles added every day. Coverage grows as your client and supplier base does.

CR Comply FAQs

What is CR Comply?

CR Comply is Cedar Rose's AML, sanctions and PEP screening product. It is part of the CRiS Intelligence platform and powered by ComplyAdvantage, so screening sits alongside your wider business research.

What does CR Comply screen against?

OFAC, UN, EU, HMT, DFSA, GCC and regional lists, plus PEP data and adverse media in 14 languages, across 250+ countries.

Can I screen the people behind a company?

Yes. Beneficial ownership and corporate linkage visibility means screening reaches the people behind an entity, not just the entity itself.

How do I access CR Comply?

Through the web platform, API or batch files. You can also configure risk thresholds so screening follows your own compliance policy.

Can I monitor clients, partners and suppliers over time?

Yes. Continuous monitoring sends instant alerts when a risk profile changes, so you never rely on a result that has gone stale.

What happens after the trial?

You can choose flexible access options, from pay-per-check to volume-based plans for high-frequency screening. There is no commitment to continue.

Is my data secure?

Cedar Rose adheres to ISO 27001 standards and meets GDPR requirements.

What types of products are available for download or request with a subscription?

With a subscription, you can download a variety of reports, including company profiles and individual directorship and shareholding reports from our comprehensive database. Subscribers also have the option to request fresh investigations on demand, ranging from company credit reports to customised due diligence reports. These reports cover AML/CTF (Anti-Money Laundering/Counter-Terrorism Financing) checks, background checks, and both enhanced and integrity due diligence investigations. In addition, the platform provides an automated global screening tool that uncovers potential sanctions, political exposure (PEP), and adverse media on various subjects. This integrated approach ensures you have access to the most relevant and up-to-date information for your compliance and risk management needs.

How long is the subscription valid?

CRiS Intelligence provides flexible subscription options to accommodate different needs. The standard subscription term is one year, with the option to renew or extend based on your requirements. For those who want to explore the platform before making a longer-term commitment, Cedar Rose offers a one-time CRiS Intelligence Discovery Package. This package includes a 3-month trial period to experience the platform's features and benefits. Clients seeking extended access beyond the standard annual term can also choose for customised subscription durations.

Can multiple users access the subscription?

Yes, the standard subscription includes access for up to 3 users. Depending on the specific subscription plan and your requirements, the number of users can be adjusted to accommodate more, or fewer users as needed. If your organisation requires additional user access or has specific needs, we can customise the subscription to fit those requirements.

Try CR Comply Free

Try CR Comply Free: AML, Sanctions and PEP Screening for MEA.

What You Can Explore in Your Trial

Don’t Let Unreliable Data Derail Your Growth!